Emeritus Status Offers Some Distinguished Faculty A Chance To Parlay Investigations On Higher Level

Just before his 71st birthday in the summer of 1982, Van Rensselaer Potter, Hilldale Professor of Oncology at the University of Wisconsin, Madison, officially retired. During his career, Potter had distinguished himself in the field of cancer research and accumulated numerous accolades for his work, including the American Cancer Society's Medal of Honor in 1986. He also had coined the term "bioethics," referring to "the equitable application of medical and biological knowledge to assuring the s

Written byA. J. S. Rayl
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

Upon retiring, Potter was by no means ready to ride off with his laurels into the sunset. He let it be known that he wanted to continue his affiliation with the University of Wisconsin, which granted him the title of "emeritus."

Potter focused most of his attention on writing a book, Global Bioethics: Building on the Leopold Legacy (Michigan State University Press, 1988)--an activity on which he had been unable to concentrate as an active faculty member. "While my book Bioethics: Bridge to the Future, wherein I coined the term `bioethics,' was published in 1971 by Prentice-Hall during the peak of my research career, it was really a compilation of lectures, and didn't require the time and effort that Global Bioethics did," says Potter. "I just never had the opportunity before becoming emeritus to write Global Bioethics, which is a much more comprehensive and all-encompassing discussion of the evolving morality ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies